Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bodor

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
Journal of Pharmaceutical Sciences|April 1, 1991
Improved delivery of acyclovir to the skin using a dihydrotrigonelline in equilibrium with trigonelline redox carrierP Chikhale, N Bodor
Pharmaceutical Research|November 1, 1991
Improved delivery through biological membranes. LVI. Pharmacological evaluation of alprenoxime--a new potential antiglaucoma agentN Bodor, A Elkoussi
Life Sciences|January 1, 1991
Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogsP Polgar, N Bodor
Die Pharmazie|July 1, 2014
Recent advances in the design and development of soft drugsP Buchwald, N Bodor
Proteins|January 27, 1998
Octanol-water partition of nonzwitterionic peptides: predictive power of a molecular size-based modelP Buchwald, N Bodor
Pharmacology & Therapeutics|April 16, 1998
Drug targeting via retrometabolic approachesN Bodor, P Buchwald
Medicinal Research Reviews|December 23, 1999
Soft drug design: general principles and recent applicationsN Bodor, P Buchwald
Die Pharmazie|March 7, 2002
Physicochemical aspects of the enzymatic hydrolysis of carboxylic estersP Buchwald, N Bodor
Current Eye Research|April 1, 1988
Novel 'soft' beta-blockers as potential safe antiglaucoma agentsN Bodor, A elKoussi
Pharmaceutical Research|July 1, 1990
Site- and stereospecific ocular drug delivery by sequential enzymatic bioactivationN Bodor, L Prokai
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Journal of Pharmaceutical Sciences|April 1, 1991
Improved delivery of acyclovir to the skin using a dihydrotrigonelline in equilibrium with trigonelline redox carrierP Chikhale, N Bodor
Pharmaceutical Research|November 1, 1991
Improved delivery through biological membranes. LVI. Pharmacological evaluation of alprenoxime--a new potential antiglaucoma agentN Bodor, A Elkoussi
Life Sciences|January 1, 1991
Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogsP Polgar, N Bodor
Die Pharmazie|July 1, 2014
Recent advances in the design and development of soft drugsP Buchwald, N Bodor
Proteins|January 27, 1998
Octanol-water partition of nonzwitterionic peptides: predictive power of a molecular size-based modelP Buchwald, N Bodor
Pharmacology & Therapeutics|April 16, 1998
Drug targeting via retrometabolic approachesN Bodor, P Buchwald
Medicinal Research Reviews|December 23, 1999
Soft drug design: general principles and recent applicationsN Bodor, P Buchwald
Die Pharmazie|March 7, 2002
Physicochemical aspects of the enzymatic hydrolysis of carboxylic estersP Buchwald, N Bodor
Current Eye Research|April 1, 1988
Novel 'soft' beta-blockers as potential safe antiglaucoma agentsN Bodor, A elKoussi
Pharmaceutical Research|July 1, 1990
Site- and stereospecific ocular drug delivery by sequential enzymatic bioactivationN Bodor, L Prokai
Pageof 21